Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease
Key facts
- Who runs it
- Can Tho University of Medicine and Pharmacy
- Where
- Vietnam1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 1 Oct 2024
- Planned end
- 30 May 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Bismuth quadruple therapy
- Triple therapy with PPI + Amoxicillin + Metronidazole
- Record updated
- 2 December 2025
Who can take part
- Age
- 5 years to 15 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Diagnosed with gastritis or peptic ulcer disease by upper gastrointestinal endoscopy or histopathology
- Meets diagnostic criteria for Helicobacter pylori infection
- Parent or legal guardian provides consent for the child to participate in the study
Who cannot take part
- Use of antibiotics or bismuth within the past 4 weeks, or use of antacids, H2-receptor antagonists, or proton pump inhibitors within the past 2 weeks
- Allergic to any of the medications in the treatment regimen
- Failure to return for follow-up visits after treatment
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 5 and 15 years old?
This trial is currently available in Vietnam.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if including bismuth in the treatment helps heal stomach and duodenal ulcers caused by Helicobacter pylori (H. pylori) in children.
Read full original descriptionShow less
The main questions it aims to answer are:
* Does a treatment plan with bismuth work better than a plan without bismuth to clear the infection? * Is the bismuth plan more cost-effective while still safe and effective?
Researchers will compare two treatment groups to see which works better. Participants will:
* Take one of the two assigned treatment plans (with or without bismuth) for the standard treatment duration * Visit the clinic for checkups and tests to confirm infection clearance and monitor side effects * Keep a diary of symptoms, medication use, and any side effects
The 2 groups in the trial
- Bismuth quadruple therapyTreatment being tested
Patients in this arm will receive PPI, Amoxicillin, Metronidazole, and Bismuth for 14 days, with doses adjusted according to weight and age.
- Triple therapy with PPI + Amoxicillin + MetronidazoleTreatment being tested
Patients in this arm will receive PPI, Amoxicillin, Metronidazole for 14 days, with doses adjusted according to weight and age.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Study on the Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease
- Criteria questions
- Built from NCT07260006, who can take part
- Record updated
- 2 December 2025